|
Volumn 59, Issue 1, 2006, Pages 11-20
|
The combination effects of antibacterial agents against clinical isolated multiple-drug resistant: Pseudomonas aeruginosa
a a a b c d e f g h i j k |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
ANTIBIOTIC AGENT;
AZTREONAM;
BIAPENEM;
CEFEPIME;
CEFTAZIDIME;
CIPROFLOXACIN;
GENTAMICIN;
IMIPENEM;
LEVOFLOXACIN;
MEROPENEM;
METALLO BETA LACTAMASE;
PAZUFLOXACIN;
PIPERACILLIN;
PIPERACILLIN PLUS TAZOBACTAM;
SULPERAZON;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACTERIAL GENE;
BACTERIAL STRAIN;
BACTERIUM CULTURE;
BACTERIUM ISOLATE;
CALCULATION;
CHECKERBOARD METHOD;
CULTURE MEDIUM;
DILUTION;
DRUG EFFICACY;
DRUG POTENTIATION;
EVALUATION;
FRACTIONAL INHIBITORY CONCENTRATION INDEX;
IMP1 GENE;
MICRODILUTION METHOD;
MINIMUM INHIBITORY CONCENTRATION;
MULTIDRUG RESISTANCE;
NONHUMAN;
POLYMERASE CHAIN REACTION;
PSEUDOMONAS AERUGINOSA;
AMIKACIN;
ANTI-BACTERIAL AGENTS;
AZTREONAM;
CEFOPERAZONE;
CEPHALOSPORINS;
CIPROFLOXACIN;
DRUG COMBINATIONS;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
DRUG THERAPY, COMBINATION;
FLUOROQUINOLONES;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
OXAZINES;
PENICILLANIC ACID;
PIPERACILLIN;
PSEUDOMONAS AERUGINOSA;
SULBACTAM;
THIENAMYCINS;
|
EID: 33645717183
PISSN: 03682781
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (10)
|